Walter & Eliza Hall Institute of Medical Research, Parkville, Australia.
Nat Immunol. 2013 Jul;14(7):741-8. doi: 10.1038/ni.2610. Epub 2013 May 19.
Functionally diverse T cell populations interact to maintain homeostasis of the immune system. We found that human and mouse antigen-activated T cells with high expression of the lymphocyte surface marker CD52 suppressed other T cells. CD52(hi)CD4(+) T cells were distinct from CD4(+)CD25(+)Foxp3(+) regulatory T cells. Their suppression was mediated by soluble CD52 released by phospholipase C. Soluble CD52 bound to the inhibitory receptor Siglec-10 and impaired phosphorylation of the T cell receptor-associated kinases Lck and Zap70 and T cell activation. Humans with type 1 diabetes had a lower frequency and diminished function of CD52(hi)CD4(+) T cells responsive to the autoantigen GAD65. In diabetes-prone mice of the nonobese diabetic (NOD) strain, transfer of lymphocyte populations depleted of CD52(hi) cells resulted in a substantially accelerated onset of diabetes. Our studies identify a ligand-receptor mechanism of T cell regulation that may protect humans and mice from autoimmune disease.
功能多样的 T 细胞群体相互作用以维持免疫系统的稳态。我们发现,人源和鼠源抗原激活的高表达淋巴细胞表面标志物 CD52 的 T 细胞能够抑制其它 T 细胞。CD52(hi)CD4(+)T 细胞与 CD4(+)CD25(+)Foxp3(+)调节性 T 细胞不同。它们的抑制作用是由 PLC 释放的可溶性 CD52 介导的。可溶性 CD52 与抑制性受体 Siglec-10 结合,并损害 TCR 相关激酶 Lck 和 Zap70 的磷酸化以及 T 细胞的激活。1 型糖尿病患者对自身抗原 GAD65 反应的 CD52(hi)CD4(+)T 细胞频率较低,功能减弱。在非肥胖型糖尿病(NOD)小鼠中,输注缺乏 CD52(hi)细胞的淋巴细胞群可导致糖尿病的发病明显加速。我们的研究确定了 T 细胞调节的配体-受体机制,可能保护人类和小鼠免受自身免疫性疾病的侵害。